‘It’s a murky business’: the row over levothyroxine use in ‘subclinical’ disease
![Illustration showing two people arguing, one 'for' and one 'against'](data:image/svg+xml,%3Csvg%20xmlns=%22http://www.w3.org/2000/svg%22%20viewBox=%220%200%20100%2056%22%3E%3C/svg%3E)
As the rising use of levothyroxine sparks concern, experts are disagreeing about how to approach the significant number of patients with conflicting levels of thyroid hormones, who often have no symptoms at all.…